These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Calabrese C; Bortolotti M; Fabbri A; Areni A; Cenacchi G; Scialpi C; Miglioli M; Di Febo G Am J Gastroenterol; 2005 Mar; 100(3):537-42. PubMed ID: 15743348 [TBL] [Abstract][Full Text] [Related]
11. Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. Severino G; Chillotti C; De Lisa R; Del Zompo M; Ardau R Ann Pharmacother; 2005 Jan; 39(1):162-4. PubMed ID: 15546944 [TBL] [Abstract][Full Text] [Related]
12. Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. DiBaise JK; Olusola BF; Huerter JV; Quigley EM Am J Gastroenterol; 2002 Apr; 97(4):843-50. PubMed ID: 12003417 [TBL] [Abstract][Full Text] [Related]
13. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis. Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S; Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850 [TBL] [Abstract][Full Text] [Related]
15. Postcoital fixed drug eruption in a man sensitive to trimethoprim-sulphamethoxazole. Gruber F; Stasić A; Lenković M; Brajac I Clin Exp Dermatol; 1997 May; 22(3):144-5. PubMed ID: 9425695 [TBL] [Abstract][Full Text] [Related]
17. [A case of fixed drug eruption due to ephedrine hydrochloride]. Tanimoto K; Shimakage T; Ayabe Y; Yamakawa T; Kumekawa M; Moriyama S Masui; 2000 Dec; 49(12):1374-6. PubMed ID: 11193515 [TBL] [Abstract][Full Text] [Related]